Oncoinvent Ord Share Price (0RU5)

ACCORD apparently now halted. Bergenbio seeking new partner in a region where Covid-19 more prevalent.

https://www.prnewswire.co.uk/news-releases/update-on-bemcentinib-s-involvement-in-potential-treatment-of-covid-19-pandemic-838369061.html

The news keeps coming: 'Bemcentinib, an AXL kinase inhibitor, will be the first to begin phase II studies across the UK within the next few days.'

https://www.pharmaceutical-journal.com/news-and-analysis/features/everything-you-should-know-about-the-coronavirus-outbreak/20207629.article

BERGENBIO-UNDER AMENDMENT PATIENTS TO POTENTIALLY RECEIVE BEMCENTINIB PLUS ONE OR BOTH OF 2APPROVED COVID-19 TREATMENTS: DEXAMETHASONE AND REMDESIVIR

"within a few weeks we'll know whether Bemcentinib has the desired effect.." Impatient as always, I wonder how long a 'few weeks' is.

bit quiet over here. I am interested but a bit of a novice. Just bought in at 39. hope its pleasant ride haha